Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
Yu K, Gu Y, Zhang P, Fang H, Cao Y, Wang J, Lin C, Liu H, Zhang H, He H, Li R, Qin J, Li H, Xu J.
Yu K, et al. Among authors: zhang p, zhang h.
Br J Cancer. 2022 Nov;127(9):1709-1717. doi: 10.1038/s41416-022-01939-8. Epub 2022 Aug 24.
Br J Cancer. 2022.
PMID: 36002752
Free PMC article.